Compare TG Therapeutics Inc (TGTX) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Zillow Group Inc Class C — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Zillow Group Inc Class C trades at $31.8 (market cap $7.54B). The key difference: TG Therapeutics Inc and Zillow Group Inc Class C are close in size by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| TGTX | Z | |
|---|---|---|
Market Cap | $8.26B | $7.54B |
Sector | Health | Media |
52-Week High | $59.06 | $90.35 |
52-Week Low | $26.39 | $29.41 |
Enterprise Value | $8.50B | $7.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
